Exploring the role of HIF-1 in early angiogenesis and response to radiotherapy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 17560674.
- Also identified by PMC identifier 2694841.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The objective of this review is to examine the role that HIF-1 plays in the initiation of angiogenesis and in radiotherapy response. Although these two phenomena may at first seem unrelated, there are parallelisms to be drawn associated with the importance of reactive oxygen species in controlling the transcriptional activity of HIF-1, independently of its main driving force, hypoxia. Knowledge of the mechanisms underlying the control of HIF-1 leads to rationale for its inhibition in a range of clinical scenarios.
Medical subject headings
- Hypoxia
- Hypoxia-Inducible Factor 1
- Neovascularization, Pathologic
- Radiotherapy